Wearable Injectors Market By Type (On-body Injectors, Off-body Injectors), By Application (Diabetes, Oncology, Cardiovascular Diseases, Autoimmune Disorders, Others), By Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Others), By End-user (Hospitals & Clinics, Homecare Settings, Specialty Centers, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025 – 2035

Published Date: Apr 2025 | Report ID: MI2462 | 210 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Product Type

  • On-body Injectors
  • Off-body Injectors

By Application

  • Diabetes
  • Oncology
  • Cardiovascular Diseases
  • Autoimmune Disorders
  • Others

By Technology

  • Spring-based
  • Motor-driven
  • Rotary Pump
  • Expanding Battery
  • Others

By End-user

  • Hospitals & Clinics
  • Homecare Settings
  • Specialty Centers
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Medtronic plc
  • Becton, Dickinson and Company (BD)
  • Johnson & Johnson
  • Insulet Corporation
  • Amgen Inc.
  • Ypsomed AG
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • Sensile Medical AG
  • Eli Lilly and Company
  • Tandem Diabetes Care, Inc.
  • Roche Diagnostics
  • Enable Injections, Inc.
  • CeQur SA
  • Stevanato Group

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing